CY1119099T1 - Διαδικασια για την παρασκευη αναστολεων του μεταβολισμου των νουκλεοζιτων - Google Patents
Διαδικασια για την παρασκευη αναστολεων του μεταβολισμου των νουκλεοζιτωνInfo
- Publication number
- CY1119099T1 CY1119099T1 CY20171100563T CY171100563T CY1119099T1 CY 1119099 T1 CY1119099 T1 CY 1119099T1 CY 20171100563 T CY20171100563 T CY 20171100563T CY 171100563 T CY171100563 T CY 171100563T CY 1119099 T1 CY1119099 T1 CY 1119099T1
- Authority
- CY
- Cyprus
- Prior art keywords
- compound
- pyrrolo
- pyrimidin
- amino
- preparing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
- C07D207/40—2,5-Pyrrolidine-diones
- C07D207/416—2,5-Pyrrolidine-diones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/14—Pyrrolo-pyrimidine radicals
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Saccharide Compounds (AREA)
- Pyrrole Compounds (AREA)
Abstract
Η εφεύρεση παρέχει μια ένωση του τύπου: όπου το Υ είναι μια μη υποκατεστημένη ή υποκατεστημένη αλκυλική ή αρυλαλκυλική ομάδα που έχει 1 έως 8 άτομα άνθρακα, καθώς επίσης και μια διαδικασία παρασκευής της αναφερθείσας ένωσης. Η εφεύρεση παρέχει επίσης μια διαδικασία παρασκευής της ένωσης 3Η,5Η-πυρρολο[3,2-d]πυριμιδιν-4-όνης, η οποία περιλαμβάνει το στάδιο της αντίδρασης μιας ένωσης του τύπου (α) που ορίζεται ανωτέρω με ένα αντιδραστήριο το οποίο έχει τη δυνατότητα χορήγησης ενός φορμυλικού ισοδυνάμου. Η εφεύρεση παρέχει επίσης μια διαδικασία παρασκευής της ένωσης 2-αμινο-3 Η ,5 Η -πυρρολο[3,2- d ]πυριμιδιν-4-όνης, που περιλαμβάνει το στάδιο της αντίδρασης της ένωσης 2-(Ν-διμεθυλαμινομεθυλεν)αμινο-6-(2-διμεθυλαμινοβινυλο)-5-νιτροπυριμιδ-4-όνης με ένα αντιδραστήριο το οποίο έχει τη δυνατότητα αναγωγής της νιτρομάδα, για την παραγωγή της ένωσης 2-αμινο-3 Η ,5 Η-πυρρολο[3,2-d ]πυριμιδιν-4-όνης.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NZ33509099 | 1999-04-08 | ||
| NZ33616899 | 1999-06-08 | ||
| EP00917509A EP1165564B1 (en) | 1999-04-08 | 2000-04-07 | Process for preparing inhibitors of nucleoside metabolism |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1119099T1 true CY1119099T1 (el) | 2018-02-14 |
Family
ID=26652045
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20091100568T CY1109103T1 (el) | 1999-04-08 | 2009-05-28 | Μεθοδος για την παρασκευη αναστολεων του μεταβολισμου νουκλεοσιδιου |
| CY20171100563T CY1119099T1 (el) | 1999-04-08 | 2017-05-31 | Διαδικασια για την παρασκευη αναστολεων του μεταβολισμου των νουκλεοζιτων |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20091100568T CY1109103T1 (el) | 1999-04-08 | 2009-05-28 | Μεθοδος για την παρασκευη αναστολεων του μεταβολισμου νουκλεοσιδιου |
Country Status (18)
| Country | Link |
|---|---|
| US (4) | US6693193B1 (el) |
| EP (2) | EP2077268B1 (el) |
| JP (2) | JP4430247B2 (el) |
| KR (1) | KR100755110B1 (el) |
| CN (2) | CN101062928B (el) |
| AT (1) | ATE425165T1 (el) |
| AU (1) | AU776540C (el) |
| CA (3) | CA2368095C (el) |
| CY (2) | CY1109103T1 (el) |
| DE (1) | DE60041757D1 (el) |
| DK (2) | DK2077268T5 (el) |
| ES (2) | ES2625636T3 (el) |
| HK (2) | HK1088310A1 (el) |
| LT (1) | LT2077268T (el) |
| NZ (1) | NZ514660A (el) |
| PT (2) | PT1165564E (el) |
| SI (2) | SI2077268T1 (el) |
| WO (1) | WO2000061783A2 (el) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5985848A (en) * | 1997-10-14 | 1999-11-16 | Albert Einstein College Of Medicine Of Yeshiva University | Inhibitors of nucleoside metabolism |
| DE60041757D1 (de) * | 1999-04-08 | 2009-04-23 | Ind Res Ltd | Verfahren zur zubereitung von inhibitoren des nukleosid-metabolismus |
| US7109331B2 (en) * | 2000-08-29 | 2006-09-19 | Industrial Research Limited | 5H-pyrrolo[3,2-d]pyrimidine nucleoside metabolism inhibitors |
| US7098334B2 (en) * | 2002-03-25 | 2006-08-29 | Industrial Research Limited | 4-amino-5H-pyrrolo[3,2-d]pyrimidine inhibitors of nucleoside phosphorylases and nucleosidases |
| BRPI0313664B8 (pt) * | 2002-08-21 | 2021-05-25 | Albert Einstein College Medicine Yeshiva Univ | compostos inibidores de nucleosídeo fosforilase e nucleosidases, suas composições e seus usos |
| NZ523970A (en) * | 2003-02-04 | 2005-02-25 | Ind Res Ltd | Process for preparing inhibitors of nucleoside phoshorylases and nucleosidases |
| US6972331B2 (en) | 2003-04-23 | 2005-12-06 | Biocryst Pharmaceuticals, Inc. | Carboxy pyrrole, process of preparing and use as precursor |
| US8017634B2 (en) | 2003-12-29 | 2011-09-13 | President And Fellows Of Harvard College | Compositions for treating obesity and insulin resistance disorders |
| NZ533360A (en) * | 2004-06-04 | 2007-02-23 | Ind Res Ltd | Improved method for preparing 3-hydroxy-4-hydroxymethyl-pyrrolidine compounds |
| NZ540160A (en) * | 2005-05-20 | 2008-03-28 | Einstein Coll Med | Inhibitors of nucleoside phosphorylases |
| CA2615549A1 (en) * | 2005-07-27 | 2007-02-08 | Albert Einstein College Of Medicine Of Yeshiva University | Transition state structure of 5'-methylthioadenosine/s-adenosylhomocysteine nucleosidases |
| NZ544187A (en) * | 2005-12-15 | 2008-07-31 | Ind Res Ltd | Deazapurine analogs of 1'-aza-l-nucleosides |
| US8394950B2 (en) * | 2006-02-22 | 2013-03-12 | Industrial Research Limited | Analogues of coformycin and their use for treating protozoan parasite infections |
| JP2009528996A (ja) * | 2006-02-24 | 2009-08-13 | インダストリアル リサーチ リミテッド | ヌクレオシドホスホリラーゼ及びヌクレオシダーゼの阻害剤を用いて疾患を処置する方法 |
| JP2009527550A (ja) * | 2006-02-24 | 2009-07-30 | アルバート アインシュタイン カレッジ オブ メディシン オブ イエシバ ユニバーシティ | 癌を処置する方法 |
| CN101094080B (zh) * | 2006-06-22 | 2012-06-20 | 华为技术有限公司 | 一种即按即通系统中的计费方法 |
| SI2057165T1 (sl) | 2006-09-07 | 2011-07-29 | Ind Res Ltd Gracefield Res Ct | Acikliäśni aminski zaviralci nukleozidnih fosforilaz in hidrolaz |
| AU2007293773B2 (en) | 2006-09-07 | 2013-01-31 | Albert Einstein College Of Medicine, Inc. | Acyclic amine inhibitors of 5'-methylthioadenosine phosphorylase and nucleosidase |
| PT2114925E (pt) * | 2006-12-22 | 2012-05-29 | Einstein Coll Med | Análogos de azetidina de inibidores de nucleosidase e fosforilase |
| CA2721927C (en) | 2008-04-21 | 2014-01-28 | Otonomy, Inc. | Auris formulations for treating otic diseases and conditions |
| US11969501B2 (en) | 2008-04-21 | 2024-04-30 | Dompé Farmaceutici S.P.A. | Auris formulations for treating otic diseases and conditions |
| US8784870B2 (en) | 2008-07-21 | 2014-07-22 | Otonomy, Inc. | Controlled release compositions for modulating free-radical induced damage and methods of use thereof |
| US20110190265A1 (en) * | 2008-09-22 | 2011-08-04 | Schramm Vern L | Methods and compositions for treating bacterial infections by inhibiting quorum sensing |
| CA2768291C (en) | 2009-07-17 | 2018-03-27 | Albert Einstein College Of Medicine Of Yeshiva University | 3-hydroxypyrrolidine inhibitors of 5'-methylthioadenosine phosphorylase and nucleosidase |
| US9290501B2 (en) | 2010-11-29 | 2016-03-22 | Albert Einstein College Of Medicine, Inc. | Methods, assays and compounds for treating bacterial infections by inhibiting methylthioinosine phosphorylase |
| JP2014505705A (ja) | 2011-02-02 | 2014-03-06 | ザ トラスティーズ オブ プリンストン ユニヴァシティ | ウイルス生成モジュレーターとしてのサーチュインモジュレーター |
| US9682093B2 (en) | 2012-03-30 | 2017-06-20 | Charles R. Drew University Of Medicine And Science | Compositions and methods for treating or preventing metabolic syndrome disorders |
| AR090699A1 (es) * | 2012-04-18 | 2014-12-03 | Biocryst Pharm Inc | Compuestos inhibidores de la actividad de la arn polimerasa viral |
| EP3478269A4 (en) | 2016-06-29 | 2020-04-08 | Otonomy, Inc. | OTIC FORMULATIONS BASED ON TRIGLYCERIDES AND THEIR USES |
| US11114184B2 (en) | 2017-02-21 | 2021-09-07 | Albert Einstein College Of Medicine | DNA methyltransferase 1 transition state structure and uses thereof |
| CN110590786B (zh) * | 2019-09-29 | 2021-12-03 | 上海大学 | 9-去氮鸟嘌呤合成工艺的改进方法 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE59307270D1 (de) * | 1992-11-06 | 1997-10-09 | Ulrich Rindlisbacher | Vorrichtung zum befestigen an einem gestell eines zweiradfahrzeugs |
| IL107616A0 (en) | 1992-11-18 | 1994-02-27 | Univ Johns Hopkins | Formation of triple helix complexes of single stranded nucleic acids using nucleoside oligomers which comprise pyrimidine analogs |
| AU1739097A (en) * | 1996-02-23 | 1997-09-10 | Albert Einstein College Of Medicine Of Yeshiva University | Enzyme detection/assay method and substrates |
| US5985848A (en) | 1997-10-14 | 1999-11-16 | Albert Einstein College Of Medicine Of Yeshiva University | Inhibitors of nucleoside metabolism |
| US6187777B1 (en) * | 1998-02-06 | 2001-02-13 | Amgen Inc. | Compounds and methods which modulate feeding behavior and related diseases |
| DE60041757D1 (de) * | 1999-04-08 | 2009-04-23 | Ind Res Ltd | Verfahren zur zubereitung von inhibitoren des nukleosid-metabolismus |
| US6448799B1 (en) * | 1999-09-30 | 2002-09-10 | Hitachi Electronics Engineering Co., Ltd. | Timing adjustment method and apparatus for semiconductor IC tester |
| US7109331B2 (en) * | 2000-08-29 | 2006-09-19 | Industrial Research Limited | 5H-pyrrolo[3,2-d]pyrimidine nucleoside metabolism inhibitors |
| US6458799B1 (en) | 2000-08-31 | 2002-10-01 | Biocryst Pharmaceuticals, Inc. | Deazaguanine analog, preparation thereof and use thereof |
| US7098334B2 (en) * | 2002-03-25 | 2006-08-29 | Industrial Research Limited | 4-amino-5H-pyrrolo[3,2-d]pyrimidine inhibitors of nucleoside phosphorylases and nucleosidases |
| BRPI0313664B8 (pt) | 2002-08-21 | 2021-05-25 | Albert Einstein College Medicine Yeshiva Univ | compostos inibidores de nucleosídeo fosforilase e nucleosidases, suas composições e seus usos |
| NZ523970A (en) * | 2003-02-04 | 2005-02-25 | Ind Res Ltd | Process for preparing inhibitors of nucleoside phoshorylases and nucleosidases |
| NZ533360A (en) | 2004-06-04 | 2007-02-23 | Ind Res Ltd | Improved method for preparing 3-hydroxy-4-hydroxymethyl-pyrrolidine compounds |
| AU2005269541A1 (en) | 2004-07-27 | 2006-02-09 | Biocryst Pharmaceuticals, Inc. | Inhibitors of 5'-methylthioadenosine phosphorylase and 5'methylthioadenosine/s-adenosylhomocysteine nucleosidase |
| NZ540160A (en) | 2005-05-20 | 2008-03-28 | Einstein Coll Med | Inhibitors of nucleoside phosphorylases |
| NZ544187A (en) | 2005-12-15 | 2008-07-31 | Ind Res Ltd | Deazapurine analogs of 1'-aza-l-nucleosides |
| JP2009528996A (ja) | 2006-02-24 | 2009-08-13 | インダストリアル リサーチ リミテッド | ヌクレオシドホスホリラーゼ及びヌクレオシダーゼの阻害剤を用いて疾患を処置する方法 |
| JP2009527550A (ja) | 2006-02-24 | 2009-07-30 | アルバート アインシュタイン カレッジ オブ メディシン オブ イエシバ ユニバーシティ | 癌を処置する方法 |
-
2000
- 2000-04-07 DE DE60041757T patent/DE60041757D1/de not_active Expired - Lifetime
- 2000-04-07 CA CA002368095A patent/CA2368095C/en not_active Expired - Lifetime
- 2000-04-07 NZ NZ514660A patent/NZ514660A/en not_active IP Right Cessation
- 2000-04-07 SI SI200031091A patent/SI2077268T1/sl unknown
- 2000-04-07 ES ES09150953.9T patent/ES2625636T3/es not_active Expired - Lifetime
- 2000-04-07 WO PCT/NZ2000/000048 patent/WO2000061783A2/en not_active Application Discontinuation
- 2000-04-07 CA CA2634299A patent/CA2634299C/en not_active Expired - Lifetime
- 2000-04-07 ES ES00917509T patent/ES2324016T3/es not_active Expired - Lifetime
- 2000-04-07 US US09/958,219 patent/US6693193B1/en not_active Expired - Lifetime
- 2000-04-07 CA CA2696826A patent/CA2696826C/en not_active Expired - Lifetime
- 2000-04-07 EP EP09150953.9A patent/EP2077268B1/en not_active Expired - Lifetime
- 2000-04-07 DK DK09150953.9T patent/DK2077268T5/en active
- 2000-04-07 EP EP00917509A patent/EP1165564B1/en not_active Expired - Lifetime
- 2000-04-07 PT PT00917509T patent/PT1165564E/pt unknown
- 2000-04-07 PT PT91509539T patent/PT2077268T/pt unknown
- 2000-04-07 DK DK00917509T patent/DK1165564T3/da active
- 2000-04-07 KR KR1020017012816A patent/KR100755110B1/ko active IP Right Grant
- 2000-04-07 CN CN2006101484657A patent/CN101062928B/zh not_active Expired - Lifetime
- 2000-04-07 SI SI200031026T patent/SI1165564T1/sl unknown
- 2000-04-07 JP JP2000611706A patent/JP4430247B2/ja not_active Expired - Lifetime
- 2000-04-07 CN CNB008084416A patent/CN1196704C/zh not_active Expired - Lifetime
- 2000-04-07 AT AT00917509T patent/ATE425165T1/de active
- 2000-04-07 LT LTEP09150953.9T patent/LT2077268T/lt unknown
- 2000-04-07 AU AU38469/00A patent/AU776540C/en not_active Expired
-
2003
- 2003-12-16 US US10/737,724 patent/US7022852B2/en not_active Expired - Lifetime
-
2005
- 2005-12-08 US US11/297,954 patent/US7211677B2/en not_active Expired - Lifetime
-
2006
- 2006-08-01 HK HK06108569A patent/HK1088310A1/xx not_active IP Right Cessation
- 2006-08-01 HK HK08102704.5A patent/HK1116472A1/xx unknown
-
2007
- 2007-03-09 US US11/716,100 patent/US7405297B2/en not_active Expired - Lifetime
-
2009
- 2009-03-30 JP JP2009080777A patent/JP5070237B2/ja not_active Expired - Lifetime
- 2009-05-28 CY CY20091100568T patent/CY1109103T1/el unknown
-
2017
- 2017-05-31 CY CY20171100563T patent/CY1119099T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1119099T1 (el) | Διαδικασια για την παρασκευη αναστολεων του μεταβολισμου των νουκλεοζιτων | |
| AU2465195A (en) | Preparation of a camptothecin derivative by intramolecular cyclisation | |
| EP1690861A3 (en) | A process for preparing duloxetine and intermediates for use therein | |
| CA2264824A1 (en) | A process for preparing 2-amino malonic acid derivatives and 2-amino-1,3-propanediol derivatives, and intermediates for preparing the same | |
| IL137617A0 (en) | Fungicidal 7-akyl-triazolopyrimidines | |
| JPS6479184A (en) | Pyrazolotriazine derivative | |
| PT1038875E (pt) | Derivados de imidazopiridina e processo para os preparar | |
| BR9810685B1 (pt) | processo para a prepraração de um composto. | |
| GB9906328D0 (en) | 2-Substituted RNA preparation | |
| ZA99614B (en) | Process for the preparation of S-alkylcysteines. | |
| ATE253553T1 (de) | Verfahren zur herstellung von 2- alkylthiobenzonitril-derivaten | |
| EP0579370A3 (en) | An optically active 1,5-disubstituted-2,4-0-isoproylidene-2,4-dihydroxypentane and a process for producing the same | |
| AU7313300A (en) | Process for the preparation of oxazole derivatives | |
| ES2164258T3 (es) | Procedimiento de preparacion de derivados de carbamoilmetilurea. | |
| GR3002699T3 (en) | Process for stabilising procaterol |